Texas Bleeding Disorders Conference 2022 Registration
News from HFA
- Scholarship Recipient: Michael Potanin
2023 HFA Educational Scholarship Johns Hopkins University, Maryland I am honored to have been chosen as a recipient of the HFA Educational Scholarship. This recognition provides immense support to me as I pursue my education and career goals. As a hemophiliac who has personally experienced the challenges of living with a genetic disorder, I am The post Scholarship Recipient: Michael Potanin appeared first on Hemophilia Federation of America.
- Scholarship Recipient: Porus Pavri
2023 HFA Educational Scholarship Rutgers University, New Jersey As an individual with hemophilia, my journey has been shaped by both challenges and determination. These experiences have propelled me towards pursuing a business major and setting ambitious future goals. I believe that the intersection of my personal circumstances and academic aspirations is a unique space where The post Scholarship Recipient: Porus Pavri appeared first on Hemophilia Federation of America.
- Blog: Random Thoughts from a Venerable Hemophiliac
At 73 and retired, I can look back on life, and wonder how I got to where I am. Seventy-three is old. You appreciate social security, Medicare, pensions, and the occasional days where arthritis isn’t winning the joint battle. You appreciate your high school girlfriend who became your wife of 52 years, your adult sons and The post Blog: Random Thoughts from a Venerable Hemophiliac appeared first on Hemophilia Federation of America.
- Novo Nordisk Announces Supply Shortage
Novo Nordisk today announced an important update about the Rebinyn®, Coagulation Factor IX (Recombinant), GlycoPEGylated 3000 IU vial size. From Novo Nordisk: In May 2023, Novo Nordisk launched the Rebinyn® 3000 IU vial size, and the demand for this vial size has outpaced our expectations. This has resulted in a temporary shortage that will lead The post Novo Nordisk Announces Supply Shortage appeared first on Hemophilia Federation of America.
- Word from Washington: January 2024
On January 16, the U.S. Department of Health and Human Services withdrew its appeal in the litigation over HHS’s copay accumulator adjuster regulation. Patient groups including HFA applauded this latest development in the lawsuit. As a reminder, patient groups led by the HIV + Hepatitis Policy Institute had filed suit against HHS, challenging its 2021 The post Word from Washington: January 2024 appeared first on Hemophilia Federation of America.